|
HS Code |
921634 |
| Product Name | Boc-L-Homophenylalanine |
| Cas Number | 72827-35-9 |
| Molecular Formula | C16H21NO4 |
| Molecular Weight | 291.34 |
| Appearance | White to off-white solid |
| Purity | Typically >98% |
| Melting Point | 74-77°C |
| Storage Temperature | 2-8°C |
| Solubility | Soluble in DMSO, methanol, and ethanol |
| Protecting Group | tert-Butyloxycarbonyl (Boc) |
| Chirality | L-isomer |
| Synonyms | N-Boc-L-homophenylalanine; Boc-4-phenyl-L-norvaline |
| Application | Amino acid derivative for peptide synthesis |
| Smiles | CC(C)(C)OC(=O)N[C@@H](CCCC1=CC=CC=C1)C(=O)O |
| Inchikey | WPAYQVZLJJKRCN-FQEVSTJZSA-N |
As an accredited Boc-L-Homophenylalanine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Boc-L-Homophenylalanine is packaged in a 25-gram amber glass bottle with a tamper-evident screw cap for secure storage. |
| Shipping | Boc-L-Homophenylalanine is shipped in secure, airtight containers to prevent moisture or contamination. It is typically transported at ambient temperature, unless otherwise specified, and complies with standard chemical shipping regulations. Proper labeling and documentation ensure safe handling, and the package is protected against physical damage during transit. |
| Storage | **Boc-L-Homophenylalanine** should be stored in a tightly sealed container in a cool, dry, and well-ventilated area, away from direct sunlight and incompatible substances such as strong acids and bases. Ideally, keep it at 2–8°C (refrigerated) to ensure maximum stability. Prevent moisture exposure, and always handle in accordance with appropriate laboratory safety protocols. |
Applications of Boc-L-Homophenylalanine in Industrial ManufacturingBoc-L-Homophenylalanine finds targeted applications as a protected amino acid intermediate across specialized pharmaceutical and peptide synthesis operations. As an established manufacturer, we configure grades, packaging, and analytical control to match the integrated requirements of downstream sectors. Below we outline verified end-use scenarios, specifying regulatory frameworks, integration points in downstream processes, typical usage ratios, and final product categories adopted by prominent industrial clients. 1. Peptide Active Pharmaceutical Ingredient (API) SynthesisPharmaceutical peptide production leverages this protected amino acid derivative for chain elongation steps in solid-phase and solution-phase synthesis routes. The material enables precise segment assembly where hydrophobic residues are required, facilitating scale-up consistency and impurity management as per GMP protocols commonly used for injectable peptide APIs targeting metabolic, oncological, and cardiovascular indications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Custom Peptide Manufacturing for Life Science ResearchResearch organizations and contract manufacturers use this compound in making complex designer peptides for academic and preclinical work. The Boc protection allows flexible incorporation of unnatural hydrophobic residues, which supports high-throughput screening programs and structure-activity relationship studies in biochemistry and molecular biology labs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Pharmaceutical Intermediate for Small Molecule SynthesisChemical manufacturers incorporate this protected amino acid as a chiral building block in the synthesis pathway of several small-molecule pharmaceutical intermediates, especially those featuring bulky, hydrophobic side chains for receptor interaction. The Boc group provides necessary protection during key condensation and cyclization reactions before removal at final stages. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Diagnostic Reagent and Analytical Reference SynthesisDiagnostics manufacturers and analytical reagent suppliers integrate this raw material as a precursor in the synthesis of labeled peptides and complex standards. The Boc-protected form offers selective access to sequence-specific structures for calibrators, control reagents, and biomarker standards requiring precise hydrophobic substitutions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Ingredient for Veterinary Drug Peptide FormulationVeterinary pharmaceutical formulators deploy the protected amino acid in the chemical synthesis of specialty peptides for animal health products. Its hydrophobic side chain is specifically valued in manufacturing active ingredients targeting hormone or receptor-based treatments in companion and livestock veterinary medicine, where peptide integrity directly affects therapeutic effectiveness and approval. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Boc-L-Homophenylalanine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Boc-L-Homophenylalanine stands as a reliable building block for peptide synthesis and the design of novel pharmaceuticals. From firsthand manufacturing experience, it is clear that meticulous care and attention to process details separates high-grade Boc-L-Homophenylalanine from lower-value alternatives. This amino acid derivative has steadily gained recognition for the consistency it brings to complex synthetic pathways, especially where purity and precision directly influence downstream results.
Chemists are always searching for structures that deliver versatility without unnecessary troubleshooting. Through years of production, we observe Boc-L-Homophenylalanine stepping into roles that demand both steric protection and an extended side chain. The Boc (tert-butyloxycarbonyl) group acts as a dependable N-terminal protecting group. This single modification allows for increased stability throughout multi-step peptide assemblies. In solution-phase or solid-phase protocols, this attribute reduces side reactions and leads to higher yield.
Researchers and industrial chemists appreciate reliable substrates. Boc-L-Homophenylalanine, with its well-defined chiral center and extended side chain, expands the options for sequence design. In synthesizing analogues of naturally occurring peptides, small changes like the insertion of homophenylalanine residues often reveal significant activity shifts in biological assays. By providing this modified amino acid with tight controls on purity and optical rotation, we help laboratories achieve reproducible outcomes, essential in both the early stages of medicinal chemistry and the demands of regulated pharmaceutical environments.
For those less familiar, the difference between standard phenylalanine and homophenylalanine lies in the structure: one extra methylene group in the side chain of the latter. That small change opens up a range of conformational properties and influences peptide folding and binding affinity in medicinal research. Protecting the amine function with a Boc group is a common practice during stepwise synthesis, since it offers controlled deprotection options under mild acid, giving chemists more flexibility during scale-up processes.
Years spent synthesizing Boc-L-Homophenylalanine have taught us that small details accumulate into big differences. We focus on controlling moisture at every step, as even trace water can trigger unwanted side reactions during the installation of the Boc group. The choice and management of solvents and reagents directly impact color, odor, and shelf life. These practical experiences allow us to offer a product that matches the shifting needs of development scientists—batch after batch, consistency remains the metric that matters.
Each lot produced passes rigorous analyses, such as HPLC for purity, optical rotation for enantiomeric excess, and NMR for structure confirmation. These tests ensure that no residual starting materials or byproducts creep into the final shipment. Over time, we noticed that poorly controlled temperatures harmed yield and led to more tarring during Boc protection. Investments in temperature-controlled reactors and hands-on staff training paid off, translating to more predictable results for end users.
Our standard model, reflecting feedback from hundreds of customer runs, supplies Boc-L-Homophenylalanine as a white to off-white crystalline powder. Purity exceeds 98% by HPLC, and water content remains below 0.5%. Each bottle carries certificates for both enantiomeric purity and residual solvent compliance—never a boxed-ticking exercise, but rather an ongoing commitment to supporting the techniques our customers actually use. Preparative scale batches often require custom packaging for solid phase systems; we offer these adjustments without diluting quality or introducing contaminants.
Laboratory scale synthesis teaches us a great deal. Often, minute impurities invisible to less sensitive techniques can stall a route or introduce artifacts in analytical readouts. Running our own diagnostics in parallel to customer feedback allows us to refine process conditions with every cycle. The shelf life of Boc-L-Homophenylalanine consistently exceeds 24 months if stored dry and protected from light, a useful margin for those timing multi-year development programs.
Handling requests for highly specific particle size distributions has shown little to no impact on peptide chemistry for Boc-L-Homophenylalanine. We prioritize the underlying chemical integrity. In day-to-day practice, avoiding cross-contamination with other protected amino acids remains a strict, in-house policy. Separate equipment, split warehouse zones, and clear labeling processes ensure that each batch matches the accompanying documentation.
Boc-L-Homophenylalanine is not limited to academic curiosity—its extended side chain enables selective interaction studies in peptide hormone analogs and receptor-ligand mapping projects. Our long-standing engagement with enzyme mimicry programs demonstrates its use in constructing novel peptides with tailored stability and selectivity. In drug development, it finds roles both as a linchpin in patentable sequence variants and as a probe in structure-activity relationship testing.
Scaling up from milligram research quantities to multi-kilogram production uncovers real-world challenges. We have modified our process chemistry and purification protocols to reduce trace contaminants that tend to concentrate during scale-up. Continuous dialogue with peptide chemists and biopharma developers gives us insight into changing regulatory specifications, enabling us to adapt without disruption. Some users have expressed surprise at how smoothly our material integrates into automated peptide synthesizers, which we attribute to tight control ranges on melting point and purity—standards set after years of observing equipment performance with actual product.
One important point from our technical support records: attempts to substitute unprotected or differently protected homophenylalanine analogues often lead to lower overall yields, harsher deprotection steps, and more cumbersome purification. By aligning our Boc-protected product with the common methodologies used in Fmoc-based or mixed strategy synthesis, repeat users achieve both higher yields and less troubleshooting.
Boc-L-Homophenylalanine doesn’t always command the same immediate recognition as Fmoc-protected analogs, but its features enable synthetic routes ill-suited to alternative protection schemes. The combination of steric bulk with acid lability makes it especially well suited for constructs where side chain branching or aromatic substitution matter. Compared to Fmoc-L-Homophenylalanine, Boc protection undergoes removal under milder, shorter acid exposure, reducing sequence scrambling and supporting sensitive peptide environments.
Homophenylalanine itself occupies a niche among non-proteinogenic amino acids. Its structural flexibility and aromatic presence bring increased hydrophobic interactions in peptides. Even subtle changes at the sequence level produce measurable effects in binding and folding. Boc protection on this backbone enables iterative design, since its deprotection rarely disrupts adjacent protecting groups or sensitive peptide bonds. In our manufacturing runs, this reliability supports more ambitious synthetic targets—those that impose tight purity windows or require extended stepwise assembly.
For comparison, alternative protected forms, such as carbobenzyloxy (Cbz)-protected or methyl ester derivatives, do not offer the same handling profile during either construction or cleavage. We have traced instances where choosing the wrong protecting group led to unnecessary losses or the introduction of byproducts, especially at scale. Boc-L-Homophenylalanine reduces those risks, thanks to well-characterized removal protocols and structural stability through various workup steps.
Our team has supported a range of peptide sequences, from small hormone mimics to much larger therapeutic candidates. In one instance, a customer working on analogues of neuroactive peptides required homophenylalanine insertion at multiple sequence positions. Standard phenylalanine did not deliver the desired activity profile. Boc-L-Homophenylalanine, through its steric spacing, opened up new avenues on their SAR tables, producing results that prompted patent filings and fresh opportunities for downstream development. Communications shared from that project, as well as our own retained samples, showed stable product even after extensive cycling between temperature extremes during transit.
On another front, an academic group used our material to prepare constrained peptide libraries for GPCR binding screens. Their feedback pinpointed high purity and minimal racemization as key advantages. Having previously experimented with Fmoc-protected forms, they found Boc-L-Homophenylalanine provided easier deprotection, crucial to avoiding unwanted backbone cleavage—a known issue in more complex scaffolds. Our close support during their process optimization helped them push several sequences into late-stage preclinical development.
The experience gained with these customers has shaped our belief in how feedback-driven manufacturing models ensure continued improvement, rather than relying on static “catalog” approaches that ignore real-world performance.
Safe and efficient storage means more than simply sealing a bottle. Time in transit, exposure to air, and temperature fluctuations contribute to potential degradation. By applying lessons from years of logistics, we pack Boc-L-Homophenylalanine with desiccant pouches and limit stock rotation cycles. Subtle but critical, this approach guarantees that researchers receive the same high-value material, whether shipped across a city or across continents.
Researchers sometimes overlook just how quickly clumped samples degrade if stored in humid conditions. Our warehouse staff monitor both packaging and warehouse humidity. We recommend tight resealing and storage away from direct light for this reason. Regular audits, random sample testing, and customer feedback loops ensure that each lot matches the physical and chemical properties expected by expert end-users.
We also provide re-testing support. Years of managing customer returns have shown us where storage conditions can diverge from best practice, so any questions about product integrity always receive prompt, technical answers. Our detailed knowledge of degradation pathways and impurity formation saves researchers time in root cause analysis.
Manufacturers play an important role in supporting applied research. Increasingly, customers approach us with scale-up challenges as they transition from discovery-phase milligram quantities to pilot-project kilogram requirements. In response, our production lines and QA processes scale without loss of quality. Personnel skilled in both hand synthesis and advanced reactor operation bridge the gap between bench and bulk. We ensure that support extends well beyond the initial order, especially as regulations on residual solvents and optical purity tighten in leading markets.
We tackle scale-up by investing in process improvement, such as refining solid-phase purification methods and exploring alternative sources for raw materials. As environmental and social governance expectations shift, we focus on greener process solvents and reduced waste generation. Regular audits and cross-functional meetings help identify bottlenecks, with engineers and chemists collaborating to design more robust workflows. Sharing learning outcomes with long-term customers invites further suggestions, making progress a shared goal rather than a top-down directive.
Most importantly, our team never assumes that yesterday’s best practice remains static. By tracking industry trends and incorporating customer feedback, we consistently introduce minor upgrades—such as more precise monitoring equipment and streamlined handling protocols—that translate into fewer complaints and higher reproducibility for end-users.
A product’s paperwork should not become an afterthought. In competitive research and pharmaceutical environments, supporting documentation for Boc-L-Homophenylalanine must match the scrutiny of regulators and auditors. Years of interfacing with QA departments taught us that clarity, completeness, and proactive updates prevent frustration and project delays. Our certificates of analysis explicitly list HPLC chromatograms, NMR spectra, and optical rotation values.
Material traceability remains a top priority—individual lot numbers connect finished product to raw material sources and process history. Investigating any potential deviation becomes more straightforward, and customers receive timely, detailed responses during audits or regulatory submissions. We stay current with changing documentation demands, including updates to global compliance regimes concerning allergens and impurity profiling.
Producing Boc-L-Homophenylalanine at scale is not without hurdles. It demands clean handling environments, consistent monitoring of critical process variables, and disciplined waste management. Trace impurities can arise from incomplete Boc installation or unoptimized workup sequences. Our approach centers on root cause analysis—once a deviation occurs, cross-disciplinary teams dissect each stage, ensuring the next batch improves upon the last. We keep thorough records of deviations and corrective actions, always searching for patterns that signal systemic issues rather than isolated events.
Continuous process monitoring, automation of reagent delivery, and staged cleaning protocols have improved our long-term product consistency. Regular engagement with raw material suppliers, combined with spot testing for undesirable trace metals and byproducts, shields our customers from unanticipated process drift. We recognize early warnings, adapt quickly, and keep communication channels open, aligning with both E-E-A-T principles and long-term trust.
Recent years have brought a surge in applications for non-standard amino acids within custom peptide synthesis and targeted drug discovery. Boc-L-Homophenylalanine’s unique side chain enables researchers to probe new protein-ligand interactions, map receptor topographies, and design drug candidates with tailored pharmacokinetics. As peptide therapeutics gain prominence in biopharma, the limitations of proteinogenic building blocks become increasingly obvious.
Manufacturers must keep pace with not only quantity demands but also rapidly evolving purity thresholds. Smaller margins for error place greater importance on process transparency, traceability, and proactive safety measures. Fielding trends in automated synthesis robotics and continuous flow chemistry, we reconfigure supply chains, tweak scale-up protocols, and optimize our analytical outputs to offer predictable, reproducible results.
By responding to the needs of both research-focused and production-driven customers, manufacturers have the responsibility to provide constructive feedback, reliable access, and technical support. Improvements are guided not by abstract marketing goals but by scientific rigor and experiential learning gained through direct production responsibility.
High-performing Boc-L-Homophenylalanine results from years of iterative learning: process refinement, next-level technical support, and an eye for practical value over glossy promotion. Chemical manufacturing requires accountability—not only in finished product, but in every batch record, every document, and every discussion with end-users. Each advancement improves not just the product, but the process and underlying culture.
Building relationships with both young and established chemists confirms that reliable materials form the basis for scientific discovery. Listening closely to customer successes—and challenges—keeps our manufacturing grounded in observable results, not assumptions. Boc-L-Homophenylalanine may be one among many protected amino acids, but the approach, care, and real-world insights invested in its production make a noticeable difference to those tackling the challenges of modern peptide chemistry.
Rather than resting on past results, we see every batch as an opportunity to learn, adapt, and contribute to scientific advancement. Our stewardship of Boc-L-Homophenylalanine, shaped by decades of on-the-ground experience, reflects a broader commitment: delivering trustworthy chemicals designed to meet tomorrow’s challenges.